Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease Margoth Moreno; Daniella A D'ávila; Marcelo N Silva; Lúcia MC Galvão; Andrea M Macedo; Egler Chiari; Eliane D Gontijo; Bianca Zingales PAGE: 918-924 | DOI: 10.1590/S0074-02762010000700014

Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina Leticia L Niborski, Vanina Grippo, Sonia O Lafón, Gabriela Levitus, Facundo García-Bournissen, Juan C Ramirez, Juan M Burgos, Margarita Bisio, Natalia A Juiz, Vilma Ayala, María Coppede, Verónica Herrera, Crescencia López, Ana Contreras, Karina A Gómez, Juan C Elean, Hugo D Mujica, Alejandro G Schijman, Mariano J Levin, Silvia A Longhi PAGE: 365-371 | DOI: 10.1590/0074-02760160006

Parasitological cure and clinical benefits of benznidazole treatment in patients from the Jequitinhonha Valley, MG, Brazil, with recent chronic infection by Trypanosoma cruzi II Marta de Lana, Lourena Tomazelli Suave, Júlio César Santoro de Oliveira Assis, Girley Francisco Machado de Assis, Matheus Marques Milagre, Glaucia Diniz Alessio, Renato Afonso Salgado, Olindo Assis Martins-Filho, Pedro Albajar-Viñas, Rosália Morais Torres DOI: 10.1590/0074-02760240229